|
| |
| |
| |
|
| |
| |
|
| |
| |
|
| Steven A. Kradjian, RAC
Mr. Kradjian had over 25 years of biopharmaceutical development experience from Vical lnc., Amgen Inc., American
Medical Optics, and Alpha Therapeutic Corporation when he founded his Consultancy in 2004 and incorporated
Conventus BioMedical Solutions in 2006. Mr. Kradjian earned an undergraduate degree in Chemistry from
Occidental College in Los Angeles, and completed the Executive Development program for Senior Regulatory Affairs
professionals at Kellogg Graduate School of Management at Northwestern University. He is certified by the Board of
Regulatory Affairs Professionals Society and has served on various industry committees, product management
committees, filed or supported numerous international clinical trial applications, and managed and participated in four
product approvals. Since 1996 Mr. Kradjian has been an Instructor and curriculum advisor in Regulatory Affairs at
UCSD Bioscience Extension and has given a number of invited lectures at industry conferences. |
| |
| Gretchen S. Jimenez, PhD, MBA
Dr. Jimenez has 20 years of research experience and recently augmented her research background by obtaining a Masters Degree in Business Administration. She brings to the table an extensive research background in Molecular Biology, with an emphasis in infectious diseases and cancer. Dr. Jimenez has experience in Product Development, Business Plan Development, Marketing Plan Development, Quality Assurance auditing, and has contributed to Investigational New Drug applications. |
| |
| Cathy Bacquet, MS
Ms. Bacquet has over 12 years of regulatory affairs experience in biologics product development and has led project teams to finalize eight Investigational New Drug (IND) applications and seven Drug Master Files (DMF). She has also audited and established document tracking/control systems. |
| |
|
|
|
|
|
| |
|
| |
|
|
|
|
|
|
| Copyright@2007 Conventus BioMedical Solutions, Inc. |
|
| |
|